PMID- 30704306 OWN - NLM STAT- MEDLINE DCOM- 20190410 LR - 20190410 IS - 1744-764X (Electronic) IS - 1474-0338 (Linking) VI - 18 IP - 3 DP - 2019 Mar TI - Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies. PG - 163-172 LID - 10.1080/14740338.2019.1577820 [doi] AB - OBJECTIVE: We aimed to summarize the current evidence regarding the risk of pneumonia associated with proton pump inhibitors (PPI) treatment. METHODS: We searched PubMed, Embase, and CENTRAL from the 1970 through December 2017. We included both randomized controlled trials (RCTs) and observational studies. We used random-effect model to calculate the summary effect estimates and quantified the heterogeneity by I(2) statistics. RESULTS: A total of 7,643,982 patients from 10 RCTs and 48 observational studies were included in this meta-analysis. The primary meta-analysis demonstrated PPIs use was significantly associated with increased risk of pneumonia, but the heterogeneity was high (odds ratio [OR], 1.43; 95% confidence interval [CI], 1.30-1.57; I(2), 95.4%). The sensitivity analysis indicated PPIs were not statistically associated with increased risk of pneumonia among patients concomitantly taking nonsteroidal anti-inflammatory drugs (OR, 1.11; 95% CI, 0.94-1.31; I(2), 5.8%). The funnel plot demonstrated significant publication bias, especially for observational studies. CONCLUSIONS: The presence of significant between-study heterogeneity and publication bias raised concerns regarding the validity of the primary meta-analytic result. Protopathic bias, or reverse causality, may cause overestimated association. Studies that adopted a design to account for protopathic bias did not show a significant association between PPI use and risk of pneumonia. FAU - Wang, Chih-Hung AU - Wang CH AD - a Department of Emergency Medicine , National Taiwan University Hospital , Taipei , Taiwan. AD - b Department of Emergency Medicine, College of Medicine , National Taiwan University , Taipei , Taiwan. FAU - Li, Cheng-Han AU - Li CH AD - c College of Medicine , National Taiwan University , Taipei , Taiwan. FAU - Hsieh, Ronan AU - Hsieh R AD - d Department of Medicine , Albert Einstein Medical Center , Philadelphia , PA , USA. FAU - Fan, Cheng-Yi AU - Fan CY AD - c College of Medicine , National Taiwan University , Taipei , Taiwan. FAU - Hsu, Tze-Chun AU - Hsu TC AD - a Department of Emergency Medicine , National Taiwan University Hospital , Taipei , Taiwan. FAU - Chang, Wei-Che AU - Chang WC AD - c College of Medicine , National Taiwan University , Taipei , Taiwan. FAU - Hsu, Wan-Ting AU - Hsu WT AD - e Department of Epidemiology , Harvard School of Public Health , Boston , MA , USA. FAU - Lin, Yu-Ya AU - Lin YY AD - f Department of Pharmacy , E-Da hospital , Kaohsiung , Taiwan. FAU - Lee, Chien-Chang AU - Lee CC AUID- ORCID: 0000-0002-1243-2463 AD - a Department of Emergency Medicine , National Taiwan University Hospital , Taipei , Taiwan. AD - b Department of Emergency Medicine, College of Medicine , National Taiwan University , Taipei , Taiwan. AD - e Department of Epidemiology , Harvard School of Public Health , Boston , MA , USA. LA - eng PT - Journal Article PT - Meta-Analysis PT - Systematic Review DEP - 20190222 PL - England TA - Expert Opin Drug Saf JT - Expert opinion on drug safety JID - 101163027 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (Proton Pump Inhibitors) SB - IM MH - Anti-Inflammatory Agents, Non-Steroidal/administration & dosage/adverse effects MH - Data Interpretation, Statistical MH - Humans MH - *Models, Statistical MH - Pneumonia/*epidemiology/etiology MH - Proton Pump Inhibitors/*administration & dosage/adverse effects MH - Publication Bias MH - Randomized Controlled Trials as Topic MH - Research Design OTO - NOTNLM OT - Meta-analysis OT - pneumonia OT - proton pump inhibitors OT - protopathic bias EDAT- 2019/02/02 06:00 MHDA- 2019/04/11 06:00 CRDT- 2019/02/02 06:00 PHST- 2019/02/02 06:00 [pubmed] PHST- 2019/04/11 06:00 [medline] PHST- 2019/02/02 06:00 [entrez] AID - 10.1080/14740338.2019.1577820 [doi] PST - ppublish SO - Expert Opin Drug Saf. 2019 Mar;18(3):163-172. doi: 10.1080/14740338.2019.1577820. Epub 2019 Feb 22.